Remove 2025 Remove Compounding Remove Medical Records
article thumbnail

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Pharmacy Times

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Materials and Methods Oncology-trained nurses review the charts of all specialty oncology medications that are due to be refilled.

article thumbnail

Psychiatric Medication Adherence in Patients Experiencing Homelessness

Pharmacy Times

Patients were excluded if they had a primary mental health diagnosis of a substance use disorder or no documented Behavioral Health Initial Assessment Form in the electronic medical record. Accessed June 2, 2025. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

Pharmacy Times

Image Credit: © Love Employee - stock.adobe.com Originally presented at the 2025 Pacific Coast Reproductive Society Annual Meeting in Indian Wells, California, the abstract highlights a real-world evaluation of outpatient step-up dosing (SUD) protocols for bispecific T-cell engagers (BiTEs).

article thumbnail

Tirzepatide, Hormone Therapy Combination Increases Weight Loss Among Postmenopausal Women

Drug Topics

Postmenopausal women with overweight or obesity who were treated simultaneously with tirzepatide and menopause hormone therapy experienced increased weight loss compared to women treated with tirzepatide alone, according to data presented at ENDO 2025, held July 12 to 15 in San Francisco, California. June 30, 2025. References 1.

article thumbnail

Influence of 5G on Healthcare

Viseven

Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. And when that data is as sensitive as medical records, the security risks increase exponentially. trillion, with a compound annual growth rate (CAGR) of 35.7%.

article thumbnail

Unlocking disease treatment with large-scale research

pharmaphorum

The power of AI is also being harnessed to sift through vast amounts of data to determine potential areas of treatment or to discover new uses for old compounds. The research programme was officially launched at the end of October 2022, and has the aim of building a resource of five million individuals’ information by 2025.